tolbutamide has been researched along with Glycogen Storage Disease Type I in 2 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GINSBERG, DM | 1 |
| Nakajima, I | 1 |
1 review available for tolbutamide and Glycogen Storage Disease Type I
| Article | Year |
|---|---|
HYPOGLYCEMIA ASSOCIATED WITH EXTRAPANCREATIC NEOPLASMS, WITH A NOTE ON OTHER UNUSUAL FORMS OF HYPOGLYCEMIA.
Topics: Adrenogenital Syndrome; Carcinoma, Hepatocellular; Drug Therapy; Glycogen Storage Disease Type I; Hu | 1964 |
1 other study available for tolbutamide and Glycogen Storage Disease Type I
| Article | Year |
|---|---|
[Histochemical study on the endocrine function of the islets of Langerhans with special reference to changes in protein-bound disulfide and sulfhydryl groups in B cells].
Topics: Adenoma, Islet Cell; Animals; Blood Glucose; Child; Chlorpropamide; Female; Glucose; Glycogen Storag | 1966 |